Delivery Order SPE2DB20D3505-SPE2DB26FYBXF
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,606.25 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities, with performance completion targeted for September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,915.46 under a firm fixed price contract. This delivery order, which is expected to be completed by September 5, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 2, 2025, with a contract value of $1,235.98 and completion date of September 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,266.83, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award was issued on September 15, 2025, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $1,020.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens (0.5 mL units) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,576.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on September 2, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is classified as a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $3,863.83 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a completion date of September 9, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award to the vendor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, serving as the company's corporate headquarters and primary...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB26FYBXFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units) under a firm fixed-price contract. The award, issued on October 23, 2025, carries a ceiling value of $1,738.55 and is set to be completed by October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a non-set-aside competitive award, consistent with the company's typical federal procurement approach. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide. Trulicity, a diabetes medication included in the company's extensive portfolio of pharmaceutical deliveries under the parent contract, demonstrates AmerisourceBergen's role as a critical vendor for federal medical procurement supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/23/25 |